Abstract: The present invention provides a weather-resistant sheet for a solar cell module, which has better adhesion to a water impermeable sheet, better blocking resistance against the water impermeable sheet, and better adhesion to EVA that is a sealant; a weather-resistant sheet for a solar cell module in which a cured coating film layer thereof can suppress UV transmission significantly; a product including the sheet; and a process for producing the sheet.

Abstract: The purpose of the present invention is to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. The present invention provides a glucokinase activator containing a compound represented by the formula (I): wherein R1 is a hydrogen atom or a halogen atom; R2 is a group represented by wherein each symbol is defined in the specification, or a salt thereof or a prodrug thereof.

Abstract: The present invention provides a weather-resistant sheet for a solar cell module, which has better adhesion to a water impermeable sheet, better blocking resistance against the water impermeable sheet, and better adhesion to EVA that is a sealant; a weather-resistant sheet for a solar cell module in which a cured coating film layer thereof can suppress UV transmission significantly; a product including the sheet; and a process for producing the sheet.

Abstract: There is provided volume holographic data recording media having a recording layer which is capable of recording interference fringes generated by interference of light having excellent coherence as fringes having different refractive indexes and undergoes holographic data recording by an amount of spatial shift distance of not more than 3 ?m which is smaller than that of conventional media.

Abstract: The present invention provides a fluorine-containing volume holographic data recording material making it unnecessary to provide a step of eliminating a specific solvent even in the case of a thick film, and having high hologram performance and good dynamic range. There is provided a composition comprising a base polymer (a), a liquid monomer (b) and a photo-initiator (c), wherein the base polymer (a) is an amorphous polymer comprising a fluorine-containing monomer as a structural unit and having a fluorine content of 26 to 80% by mass, the liquid monomer (b) comprises at least one liquid monomer (b1) initiating polymerization by means of activated species generated from the photo-initiator (c), the photo-initiator (c) is a compound causing the liquid monomer (b1) to initiate polymerization by exposure to light having excellent coherence and, and a refractive index of the liquid monomer (b) is higher than an average refractive index of a mixture of the base polymer (a) and the photo-initiator (c).

Abstract: There is provided a back sheet of solar cell and a solar cell module where adhesion to a water-impermeable sheet is improved and adhesion to an ethylene/vinyl acetate copolymer is further improved. The back sheet of the solar cell module has, at least on either surface of a water-impermeable sheet, a cured coating film layer of a coating containing a hydroxyl-containing fluoropolymer and an isocyanate prepolymer and/or melamine resin as a curing agent.

Abstract: The purpose of the present invention is to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. The present invention provides a glucokinase activator containing a compound represented by the formula (I): wherein R1 is a hydrogen atom or a halogen atom; R2 is a group represented by wherein each symbol is defined in the specification, or a salt thereof or a prodrug thereof.

Abstract: The purpose of the present invention is to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. The present invention provides a glucokinase activator containing a compound represented by the formula (I): wherein R1 is a hydrogen atom or a halogen atom; R2 is a group represented by wherein each symbol is defined in the specification, or a salt thereof or a prodrug thereof.

Abstract: There is provided volume holographic data recording media having a recording layer which is capable of recording interference fringes generated by interference of light having excellent coherence as fringes having different refractive indexes and undergoes holographic data recording by an amount of spatial shift distance of not more than 3 ?m which is smaller than that of conventional media.

Abstract: The present invention provides a fluorine-containing volume holographic data recording material making it unnecessary to provide a step of eliminating a specific solvent even in the case of a thick film, and having high hologram performance and good dynamic range. There is provided a composition comprising a base polymer (a), a liquid monomer (b) and a photo-initiator (c), wherein the base polymer (a) is an amorphous polymer comprising a fluorine-containing monomer as a structural unit and having a fluorine content of 26 to 80% by mass, the liquid monomer (b) comprises at least one liquid monomer (b1) initiating polymerization by means of activated species generated from the photo-initiator (c), the photo-initiator (c) is a compound causing the liquid monomer (b1) to initiate polymerization by exposure to light having excellent coherence and, and a refractive index of the liquid monomer (b) is higher than an average refractive index of a mixture of the base polymer (a) and the photo-initiator (c).

Abstract: The purpose of the present invention is to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. The present invention provides a glucokinase activator containing a compound represented by the formula (I): wherein R1 is a hydrogen atom or a halogen atom; R2 is a group represented by wherein each symbol is defined in the specification, or a salt thereof or a prodrug thereof.

Abstract: The purpose of the present invention is to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. The present invention provides a glucokinase activator containing a compound represented by the formula (I): wherein R1 is a hydrogen atom or a halogen atom; R2 is a group represented by wherein each symbol is defined in the specification, or a salt thereof or a prodrug thereof.